MANA RBM   Report issue

For profit Phase 3
Founded: Denver CO United States (2012)

Organization Overview

First Clinical Trial
2020
NCT04237584
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

MANA RBM